Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy Plus Amifostine in Treating Patients With Metastatic or Unresectable Cancer
This study is ongoing, but not recruiting participants.
Study NCT00003657 Information provided by National Cancer Institute (NCI)
First Received: November 1, 1999 Last Updated: February 6, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Bladder Cancer
Carcinoma of Unknown Primary
Extragonadal Germ Cell Tumor
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Sarcoma
Testicular Germ Cell Tumor
Additional conditions recognized in this trial
Carcinoma
Carcinoma, Renal Cell
Central Nervous System Neoplasms
Head and Neck Neoplasms
Kidney Neoplasms
Lung Neoplasms
Neoplasms, Germ Cell and Embryonal
Neoplasms, Unknown Primary
Nervous System Neoplasms
Neuroectodermal Tumors, Primitive, Peripheral
Ovarian Neoplasms
Urinary Bladder Neoplasms
More general conditions related to this trial
Adenocarcinoma
Adnexal Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Kidney Diseases
Lung Diseases
Neoplasm Metastasis
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Connective and Soft Tissue
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Neuroepithelial
Neoplastic Processes
Nervous System Diseases
Neuroectodermal Tumors
Neuroectodermal Tumors, Primitive
Ovarian Diseases
Pathologic Processes
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Urinary Bladder Diseases
Urogenital Neoplasms
Urologic Diseases
Urologic Neoplasms
Interventions listed in this trial
filgrastim
amifostine trihydrate
carboplatin
etoposide
ifosfamide
Additional drug interventions recognized in this trial
Amifostine
Etoposide phosphate
Isophosphamide mustard
More general drug interventions related to this trial
Alkylating Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Phytogenic
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Radiation-Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Dana-Farber Cancer Institute
Back to top of Main Content
